OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Charity number 277326

Company number 01393034

ADDENBROOKE'S KIDNEY PATIENTS ASSOCIATION LTD

( a company limited by guarantee )

ACCOUNTS

31 MARCH 2023

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD CHARITY INFORMATION FOR THE YEAR ENDED 31 MARCH 2023

Trustees

A C Collins (Deputy Treasurer) N Moncrieff (Resigned 3/10/22) B A Wood (Treasurer) R M Jarvis (Resigned 5/2/23) R Slattery S Peers J Man M Harnor A J Norton (Resigned 18/5/22) S C Rook (Resigned 7/10/22) P Smyth (Chairman) L Banks (Appointed 6/3/23) Glen Smith (Appointed 6/3/23)

Secretary

A C Collins

Registered Office

23 Constable Road Haverhill Suffolk CB9 7FQ

Bankers

Barclays Bank PLC 25 High Street Ely Cambridgeshire CB7 4FS

Company number

1393034

Charity number 277236

1

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023

The trustees are pleased to present their annual directors’ report together with the financial statements of the charity for the year ended 31st March 2023, which are also prepared to meet the requirements for a directors’ report and Companies Act purposes.

The financial statements comply with the Charities Act 2011, the Companies Act 2006, the Memorandum and Articles of Association, and Accounting and Reporting by Charities: Statements of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015).

PURPOSE AND ACTIVITIES

Founded in 1978, Addenbrooke’s Kidney Patients Association Ltd (AKPA) has grown into an important local patient support group providing much-needed services not supplied by the NHS.

Mission Statement : Addenbrooke’s Kidney Patients Association Ltd is a charitable Trust committed to improving the quality of life of people suffering from kidney disease who are, or have been treated at Addenbrooke’s Hospital.

The objectives of the Trust are : to promote the relief of persons suffering from renal disease and to educate the public in the needs of such persons by encouraging public awareness and understanding of renal diseases, treatments and research.

Regular Commitments

Welfare grants to needy patients and their families

Special Projects

Past and ongoing support includes:-

2

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023

The role and contribution of volunteers:

During the year approx. fifteen volunteers helped support the work of AKPA through it’s fundraising activities.

Achievements and Performance

Charitable activities;

We continued to provide support for renal patients treated at Addenbrooke's Hospital Renal Department; in the Dialysis Centre, its three satellite units and transplant wards.

During this financial year we funded:

Welfare services; - Our expenditure on welfare and dialysis holiday awards to sick and needy patients totalled £24,044. These awards are approved by two trustees following recommendations by the Renal Social Worker.

Patients’ Christmas Parties; - The usual Christmas buffets for patients receiving treatment over the Christmas period at CDC and satellite units was cancelled due to covid precautions. In place of these the charity funded Christmas presents for all those dialysing over Christmas at a cost of £2,029.

AKPA is affiliated to the National Kidney Federation (NKF) who provide information and represent patients at a national level. AKPA subscriptions for this affiliation are currently deferred by our participation in the NKF national raffle.

Advertising and Publicity: We created a new website at an initial cost of £1,400.Content creation and updating will be done by trustees. The work of writing and editing our newsletter is also done free of charge by another trustee, although the layout and printing are paid for.

Special Projects: total £49,700. These are projects outside of our regular remit and usually of short duration, they included : -

Mobile phones: £1,935 - for use by the Dialysis Patient Counsellors and selected vulnerable patients.

Bradley / Summers Research Project: £22,445 - research to be carried out at Addenbrooke's to improve number of organs available for transplantation. Numed Monitor: £1,899 - p ortable blood pressure and vital signs monitor for Hinchingbrooke satellite dialysis unit.

Baxter Booklets £1,160 – re-print of advice booklets for patients starting dialysis. Able Assist patient transporter £849 – for Hinchingbrooke satellite unit Lumie Lamps £214 – for nurse work stations

Mindray Ultrasound scanner £15,600 – portable fistula scanning machine for use in units and home dialysis.

Benefits at Work handbook £97 for patient welfare advice. Lofty Heights house cleaning £1,614 - help for a home dialysis patient. Health and Care Overlay cushions £3,887 – re-placement cushions for dialysis chairs at Hinchingbrooke satellite unit.

3

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023

Charitable income:

Our hardworking fundraisers achieved success with the Christmas Raffle, 200 club, Christmas card sales and collecting tins raising a total of £4,588. Other fundraising activities organised by patients and their families raised a total of £16,417

The Association is fortunate in having many voluntary fundraisers, none of our fundraisers are paid for their work and we are very grateful to them. Income from websites such as JustGiving.com and easyFundraising, and regular donations through Standing Orders are both significant sources of income. Income from donations totalled £1,749.

We were again fortunate this year in receiving legacies totalling £5,469.

Income from In Memory donations totalled £4,941and income earned by our reserves invested in high interest accounts totalled £2,826.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing Document : Addenbrooke’s Kidney Patients Association Ltd (the word ‘Limited’ being omitted by licence from the Department of Trade) is registered as a company limited by guarantee and not having a capital divided by shares.

The company was incorporated on 9 October 1978 and is a registered charity constituted as a Limited Company under the Memorandum and Articles of Association. The charity registration number is 277236 and the company registration number is 01393034.

Recruitment and appointment of Trustees: the trustees are elected at the Annual General Meeting in line with AKPA policy. New trustees are invited to stand for election or by introduction through services or by direct recruitment. The selection process includes an analysis of skills required by the board, interviews with the Director and Chair of the board and attendance at the board meeting followed by a review.

The Trustees have no beneficial interest in the company other than as members. The Trustees are also the directors of the company. All of the Trustees are members of the company and guarantee to contribute £1 in event of winding up. The Directors of the organisation are also the charity trustees for the purposes of charity law.

Trustee induction and training: new trustees receive an induction pack outlining their responsibilities and duties and meet individually with Chair as part of their induction. Up to four additional individuals with special knowledge or experience can be co-opted to serve as non voting members of the executive committee.

Organisation: the Directors and Trustees meet regularly in order to manage the affairs of the company, with the Board meeting approximately every two months. The Management Board comprises individuals from a variety of backgrounds, stakeholders and users. Board members’ backgrounds include care and advice professions as well as finance and management.

4

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023

Related parties: The charity works closely with other similar organisations as detailed in the “Achievements and Performance” section of the Trustees Report . None of the charity’s trustees are directors or trustees of these other organisations.

Risk Management

The trustees assess major risks to which AKPA is exposed. Trustees review the risks to which the organisation is exposed on a regular basis, documenting the potential impact of each risk, recording actions planned to reduce the potential impact of risks and monitoring progress in the minutes.

FINANCIAL REVIEW

Principal Funding Sources: current principal funding sources are fundraising activities, donations, legacies and interest from reserves, as detailed above.

Investment powers and policy:

Under the Memorandum and Articles of Association, the charity has the power to make any investment which the trustees see fit. The trustees have considered the most appropriate policy for investing funds and have found that cash deposits meet their requirements to generate income.

Reserves policy:

The Directors and Trustees consider it prudent to maintain an adequate level of unrestricted reserves to cover commitments and provide sufficient working capital.

The receipt of legacies in recent years has boosted our reserves. The charity will continue to seek projects that are important to the wellbeing of kidney patients treated by Addenbrooke's Hospital to utilise funds currently held in our reserves.

The Directors consider that the Charity's reserves are at a level that will allow the charity to continue providing services for the foreseeable future and to allow them to enhance the services provided should future donations allow. The reserves held in unrestricted funds, which have not been designated or invested in fixed assets, at the 31st March 2023 were £264,446 (2022: £313,717).

FUTURE ACTIVITIES

The AKPA Board has discussed work that it would like to progress over 2022/23. AKPA will seek to facilitate and further improve services and activities as follows.

Continued funding of smart phones up to a cost of £2,340 p.a.for use by the Dialysis Patient Counsellors and selected vulnerable patients. These have proved invaluable for communication between Nursing Staff, Counsellors and vulnerable patients.

5

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023

Funding a Fistula Ligation Study: up to a cost of £16,860, This study is investigating the long term health effects of dialysis fistulas.

Cushions and Overlays £7,151 – replacements for Cambridge Dialysis Centre.

Dressing Trolleys at a cost of £997 – for Hinchingbrooke dialysis unit

Continuing support for dialysis patients , including welfare and dialysis holiday payments. Plus funding for patient comforts and equipment not supplied by the NHS to Addenbrooke’s Renal Units.

During the upcoming year, AKPA will continue to develop partnerships with statutory, voluntary and NHS organisations.

TRUSTEES’ RESPONSIBILITIES IN RELATION TO THE FINANCIAL STATEMENTS

The Trustees (who are also directors of the Addenbrooke’s Kidney Patients Association Ltd for the purposes of company law) are responsible for preparing the Trustees’ Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities

The report of the directors has been prepared taking advantage of the small companies’ exemption of section 415A of the Companies Act 2006.

APPROVED BY THE BOARD on 04/09/2023 AND SIGNED ON ITS BEHALF BY:

Mr B A Wood

6

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD

Independent examiners report

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2023 set out on pages 8 to 13.

As the charity’s trustees of the Company (who are also the directors of the company for the purposes of company law), you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (“the 2006 Act”).

Having satisfied myself that the accounts of the Company are not required to be audited for this year under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (“the 2011 Act”). In carrying out my examination, I have followed the Directions given by the Charity Commission (under section 145(5)(b) of the 2011 Act.

I have completed my examination. I confirm that no material matters have come to my attention which gives me cause to believe that:

• the accounts do not comply with relevant accounting requirements under section 396 of the Companies Act 2006 other than any requirement that the accounts give a ‘true and fair’ view which is not a matter considered as part of an independent examination; or

04/09/2023

Richard Simons Chartered Accountant 98 Norwich Road Horstead Norwich NR12 7EQ

7

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2023

Note
Incoming resources
Incoming resources from
generated funds:
Voluntary income
Investment income
Other incoming resources
Total incoming resources
2
Resources expended
Charitable Activities
3
Cost of generating funds
Governance costs
Total resources expended
Net incoming /(outgoing)
resources
Total funds at 1 April 2022
Transfer
Total funds at 31 March 2023
Unrestricted
Restricted
Total
Total
Fund
fund
fund
Fund
2023
2022
£
£
£
£
21886
21886
92180
2826
2826
1251
13165
13165
15206
37877
0
37877
108637
76810
76810
35290
8082
0
8082
6176
2256
0
2256
1453
87148
0
87148
42919
(49271)
0
(49271)
65718
313717
1027
314744
249026
264446
1027
265473
314744
264446
1027
265473
314744

8

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD BALANCE SHEET AS AT 31 MARCH 2023

Fixed assets
Tangible fixed assets
Current assets
Stock
Shawbrook Bank Account
Close Brothers Account
Building Society Deposit
Cash at bank and in hand
Creditors
Amounts falling due within one year
Net current assets
Total assets less current liabilities
Funds
Restricted funds
Unrestricted funds
Total funds
2023
£
2230
66955
88170
78853
29865
£
0
265473
2022

£
1599
66955
86099
78447
82244
£
0
314744
266073
600
315344
600
265473 314744
1027
264446
1027
313717
265473 314744

The Trustees consider that the company is entitled to exemption from the requirement to have an audit under the provisions of section 477 of the Companies Act 2006 ("the Act") and section 144(2) of the Charities Act 2011.

The members have not required the charity to obtain an audit on its accounts for the year in question in accordance with section 476 of the Act.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of the financial statements.

The notes on pages 10 to 13 form part of these financial statements.

Brian Wood Director

Approved by the board on 04/09/2023

9

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

1 Accounting policies

• Basis of preparation of financial statements

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Reconciliation with previous Generally Accepted Accounting Practice

In preparing these accounts, the Trustees have considered whether in applying the accounting policies required by FRS 102 and the Charities SORP FRS 102 the restatement of comparative items was required.

No restatements were required.

Company status

charity being wound up, the liability in respect of the guarantee is limited to £l per member of the company.

Income

Voluntary income including donations and legacies is recognised where there is entitlement, certainty of receipt and the amount can be measured with sufficient reliability

Incoming resources from tax claims are included in the statement of financial activities at the same time as the gift to which they relate

Shop income is recognised as earned (that is as the related goods or services are provided)

Investment income is recognised on a receivable basis

Expenditure

Liabilities are recognised as soon as there is a legal or constructive obligation committing the charity to the expenditure. All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to that category

Costs of generating funds are the costs of trading for fundraising purposes

Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them

Grants payable are payments to third parties in the furtherance of the charitable activities. Where the charity gives a grant with conditions for its payment being a specific of service or output to be provided, such grants are only recognised in the SOFA once the recipient of the grant has provided the specific service or output

Grants payable without performance conditions are only recognised in the accounts when a commitment has been made and there are no conditions to be met relating to the grant which remain in the control of the charity.

10

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

Provisions for grants are made when the intention to make a grant has been communicated to the recipient but there is uncertainty about either the timing of the grant or the amount of grant payable.

Governance costs include costs of the preparation and examination of the statutory accounts, the costs of trustee meetings and the cost of any legal advice to trustees or governance or constitutional matters

Fixed assets

Individual fixed assets costing £l or more are initially recorded at cost

A review for impairment of a fixed asset is carried out if events or changes in circumstances indicate that the carrying value of any fixed asset may not be recoverable. Shortfalls between the carrying value of fixed assets and their recoverable amounts are recognised as impairments. Impairment losses are recognised in the Statement of Financial Activities Incorporating Income and Expenditure Account.

Tangible fixed assets are carried at cost, net of depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant and machinery

15% straight line

• Stocks

Stock is valued at the lower of cost and net realisable value after due regard for obsolete and slow moving stocks. Net realisable value is based on selling price less anticipated costs to completion and selling costs. Items donated for sale or distribution are not included in the financial statements until they are sold or distributed

Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the company; this is normally upon notification of the interest paid or payable by the Bank.

11

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

2 Charitable income
Interest receivable and similar income
Street and supermarket collections
General fund raising
200 club income
Subscriptions
Collecting tins
In Memory
Charities aid
Legacies
Raffle
General donations
Gift aid donations
Christmas card income
2023
£
£
2826
0
16417
2172
0
350
4941
0
5469
1297
911
837
2657
37877
2022
£
£
1251
0
13556
2292
0
732
4720
38
78548
1650
2780
965
2105
108637
3 Direct charitable expenditure
Patients welfare
Patients holiday grants
Medical staff training
Patients Christmas party
Transplant games
NKF conference
Special projects
Printing Stationery and postage
2023
£
£
23140
904

39
2029
500
0
49700
498
76810
2022
£
£
13213
117
138
2141
0
0
19202
479
0
35290

12

ADDENBROOKE’S KIDNEY PATIENTS ASSOCIATION LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

2023 2022
4 Net incoming resources/(resources expended) £ £
This is stated after charging:
Independent examination fees 600 600
5 Trustees' remuneration and expenses

No trustees received any remuneration or benefits in kind during the year.

6 Taxation

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.

7 Restricted funds

Mrs. J. Wood memorial
fund
Antibody removal
fund
Balance
Incoming
Outgoing
Transfer
Balance
1.4.22
Resources
Resources
Gen Fund
31.3.23
1027
0
1027
-
-
1027
0
0
0
1027

13